Stocks were wobbling between small gains and losses in morning trading Monday ahead of a wave of earnings reports from big U.S. companies coming out this week.
The S&P 500 index was up 0.1% as of 11:40 a.m. Eastern. The Dow Jones Industrial Average was up 67 points, or 0.2%, to 34,936 and the Nasdaq composite was mostly unchanged. On Friday, the S&P 500 rose 1.1% to a fresh record, rebounding from the previous day’s loss.
Stocks in the benchmark S&P 500 were roughly split between gainers and losers with bank stocks rising solidly and technology stocks falling. Trading was muted, with a few stocks making big moves on little news.
L Brands jumped 4.1% after the company's board approved splitting the Victoria’s Secret and Bath & Body Works units into two separate companies. Virgin Galactic fell 12.2% followed up a successful spaceflight with plans to sell up to $500 million in stock.
Earnings season kicks off this week. The big Wall Street banks report their results starting Tuesday starting with JPMorgan Chase and Goldman Sachs. Also reporting this week will be Bank of America, Citigroup and Wells Fargo. A handful of other big companies report this week, including Delta Air Lines, PepsiCo and UnitedHealth Group.
Expectations are high this quarter for publicly traded companies. The pandemic is waning, and all of the United States effectively reopened again in the last quarter as vaccine availability became widespread. Investors will be looking to see not only what sort of profits these companies brought in the last three months, but also what their outlook is now that things are normalizing.
Corporate earnings are expected to be up 64% from a year earlier, according to FactSet. That would be the biggest year-over-year growth since 2009, when corporate profits started recovering from the Great Recession.
Ultimately investors are going to need these companies to deliver this season. Stocks have risen sharply in the past year on the backs of expectations that corporate profits would rebound once the pandemic ends. Without strong profits, it will be increasingly difficult for investors to justify these high stock prices and record market valuations.
“This needs to be more of a confirmation process this earnings season,” said Scott Wren.
Investors are closely watching what companies say about the future in the latest round of earnings, now that the economy is shaking off the worst impact from the pandemic and companies have a clearer view ahead.
“The market has an expectation for the economy and interest rates and it's a matter of whether company's are going to acknowledge this or are they going to be cautious,” Wren said. “The market would like to see some certainty.”
As investors keep an eye on corporate earnings, there are also lingering worries about the highly contagious delta coronavirus variant that is spreading quickly across much of the world. Places in the U.S. being hit particularly hard by the delta variant include the South, where vaccine hesitancy and resistance is more common. There are some worries that these areas may have to reimpose restrictions.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
